Seasoned corporate finance executive and board director with experience in private equity, strategic M&A and operational leadership across mid-market technology and healthcare companies. Dianne Marie Morin combines CFO-level financial planning and capital markets expertise with transaction execution and investor relations acumen. Known for driving restructuring, integration and margin improvement programs, she advises on capital raising, governance and portfolio company value creation for sponsors and family offices.
Seasoned corporate finance executive and board director with experience in private equity, strategic M&A and operational leadership across mid-market technology and healthcare companies. Dianne Marie Morin combines CFO-level financial planning and capital markets expertise with transaction execution and investor relations acumen. Known for driving restructuring, integration and margin improvement programs, she advises on capital raising, governance and portfolio company value creation for sponsors and family offices.
Operates with a value-creation, operationally focused investment philosophy that prioritizes mid-market technology and healthcare opportunities where active financial stewardship and governance can accelerate growth. Emphasizes rigorous FP&A, capital structure optimization, and disciplined M&A to drive margin expansion and integration outcomes. Favors sponsor and family-office partnerships, multi-year horizon, targeted restructuring, and measurable KPI-driven turnaround plans to de-risk capital and enhance exit optionality.
Operates with a value-creation, operationally focused investment philosophy that prioritizes mid-market technology and healthcare opportunities where active financial stewardship and governance can accelerate growth. Emphasizes rigorous FP&A, capital structure optimization, and disciplined M&A to drive margin expansion and integration outcomes. Favors sponsor and family-office partnerships, multi-year horizon, targeted restructuring, and measurable KPI-driven turnaround plans to de-risk capital and enhance exit optionality.
| Trades 2403 | Longs Won 1603/2403 66% | Profit Factor 7.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $257,570.29 |
| Average Win $70,618.78 | Best Trade (Jul 22) $10.32M | Sharpe Ratio -14.38 |
| Average Loss -$17,824.11 | Worst Trade (Jul 24) -$723,801.28 | Z-Score 10.3 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1w 1d | Expectancy $41,162.38 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 41,667 | 37,500 | 33,333 | 29,167 | 25,000 | 20,833 | 16,667 | 12,500 | 8,333 | 4,167 |